• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 425 filed by Lakeshore Acquisition I Corp.

    12/1/22 6:02:03 AM ET
    $LAAA
    Get the next $LAAA alert in real time by email
    425 1 tm2231736d1_8k.htm 425

     

     

    United States

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Form 8-K

     

    Current Report

    Pursuant to Section 13 or 15(d) of the

    Securities Exchange Act of 1934

     

    November 28, 2022

    Date of Report (Date of earliest event reported)

     

    Lakeshore Acquisition I Corp.

    (Exact Name of Registrant as Specified in its Charter)

     

    Cayman Islands   001-40474   N/A
    (State or other jurisdiction of
    incorporation)
     

    (Commission File Number)

     

      (I.R.S. Employer
    Identification No.)

     

    Suite A-2F, 555 Shihui Road, Songjiang District,

    Shanghai, China

      201100
    (Address of Principal Executive Offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: +86 13816100700

     

    N/A

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    x Written communications pursuant to Rule 425 under the Securities Act
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Ordinary Shares   LAAA   The Nasdaq Stock Market LLC
    Warrants   LAAAW   The Nasdaq Stock Market LLC
    Units   LAAAU   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    IMPORTANT NOTICES

     

    Important Notice Regarding Forward-Looking Statements

     

    This Current Report on Form 8-K contains certain “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, both as amended. Statements that are not historical facts, including statements about the pending transactions among Lakeshore Acquisition I Corp. (together with its successors, the “Purchaser”), LAAA Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser (the “Merger Sub”), ProSomnus Holdings Inc., a Delaware corporation (“ProSomnus”), HGP II, LLC, a Delaware limited liability company, as the representative of the stockholders of ProSomnus, and RedOne Investment Limited, a British Virgin Islands company, as the representative of the stockholders of Purchaser, and the transactions contemplated thereby, and the parties’ perspectives and expectations, are forward-looking statements. Such statements include, but are not limited to, statements regarding the proposed transaction, including the anticipated initial enterprise value and post-closing equity value, the benefits of the proposed transaction, integration plans, expected synergies and revenue opportunities, anticipated future financial and operating performance and results, including estimates for growth, the expected management and governance of the combined company, and the expected timing of the transactions. The words “expect,” “believe,” “estimate,” “intend,” “plan” and similar expressions indicate forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to various risks and uncertainties, assumptions (including assumptions about general economic, market, industry and operational factors), known or unknown, which could cause the actual results to vary materially from those indicated or anticipated.

     

    Such risks and uncertainties include, but are not limited to: (i) the occurrence of any event, change or other circumstances that could delay the business combination or give rise to the termination of the agreements related thereto; (ii) the outcome of any legal proceedings that may be instituted against Purchaser or ProSomnus following announcement of the transactions; (iii) the inability to complete the business combination due to the failure to obtain approval of the shareholders of Purchaser, or other conditions to closing in the merger agreement; (iv) the risk that the proposed business combination disrupts ProSomnus’s current plans and operations as a result of the announcement of the transactions; (v) ProSomnus’s ability to realize the anticipated benefits of the business combination, which may be affected by, among other things, competition and the ability of ProSomnus to grow and manage growth profitably following the business combination; (vi) costs related to the business combination; (vii) risks related to the rollout of ProSomnus’s business and the timing of expected business milestones; (viii) ProSomnus’s ability to maintain effective internal controls over financial reporting; (ix) the effects of competition on ProSomnus’s future business; (x) risks related to ProSomnus’s dependence on its intellectual property and the risk that ProSomnus’s technology could have undetected defects or errors; (xi) changes in applicable laws or regulations; (xii) the COVID-19 pandemic and its effect directly on ProSomnus and the economy generally; (xiii) risks related to disruption of management time from ongoing business operations due to the proposed business combination; and (xiv) the possibility that ProSomnus may be adversely affected by other economic, business, and/or competitive factors. A further list and description of risks and uncertainties can be found in Purchaser’s initial public offering prospectus dated June 10, 2021 , in Purchaser’s quarterly reports on Form 10-Q and annual reports on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) subsequent thereto and in the Registration Statement on Form S-4 and proxy statement filed with the SEC by LAAA Merger Sub Inc. in connection with the proposed transactions, and other documents that the parties may file or furnish with the SEC, which you are encouraged to read. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those indicated or anticipated by such forward-looking statements. Accordingly, you are cautioned not to place undue reliance on these forward-looking statements. Forward-looking statements relate only to the date they were made, and Purchaser, Merger Sub, ProSomnus, and their subsidiaries undertake no obligation to update forward-looking statements to reflect events or circumstances after the date they were made except as required by law or applicable regulation.

     

     

     

     

    Additional Information and Where to Find It

     

    In connection with the transaction described herein, Purchaser and LAAA Merger Sub Inc. have filed relevant materials with the SEC, including a Registration Statement on Form S-4 and a proxy statement. The proxy statement and a proxy card have been mailed to Purchaser’s stockholders as of the record date established for voting at the stockholders’ meeting relating to the proposed transactions. Stockholders will also be able to obtain a copy of the Registration Statement on Form S-4 and proxy statement without charge from Purchaser. The Registration Statement on Form S-4 and proxy statement may also be obtained without charge at the SEC’s website at www.sec.gov or by writing to Purchaser at 667 Madison Avenue, New York, NY 10065.

     

    INVESTORS AND SECURITY HOLDERS OF PURCHASER ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS IN CONNECTION WITH THE TRANSACTIONS THAT PURCHASER WILL FILE WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT PURCHASER, PROSOMNUS AND THE TRANSACTIONS.

     

    Participants in Solicitation

     

    Purchaser, Merger Sub, ProSomnus, certain stockholders of ProSomnus, and their respective directors, executive officers and employees and other persons may be deemed to be participants in the solicitation of proxies from the holders of Purchaser common stock in respect of the proposed transaction. Information about Purchaser’s directors and executive officers and their ownership of Purchaser’s ordinary shares is set forth in Purchaser’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC. Other information regarding the interests of the participants in the proxy solicitation will be included in the proxy statement pertaining to the proposed transaction when it becomes available. These documents can be obtained free of charge from the sources indicated above.

     

     

     

     

     

     Item 1.01 Entry into a Material definitive Agreement.

     

    On November 28, 2022, Lakeshore Acquisition I Corp., a Cayman Islands exempted company (“Purchaser” or “Lakeshore”), and ProSomnus Holdings Inc., a Delaware corporation (“ProSomnus”), entered into an Amended and Restated Purchaser Support Agreement (the “Amended and Restated Purchaser Support Agreement”), with the initial shareholders of the Purchaser (the “Supporters”), which amends and restates the Purchaser Support Agreement, dated May 9, 2022. Pursuant to the Amended and Restated Purchaser Support Agreement, the Supporters agreed to automatically (and with no further action by the Supporters) transfer an additional 12% of the Founder Shares (as defined in the Purchaser Support Agreement) to Equity Investors (as defined in the Purchaser Support Agreement) for no consideration. As a result the Supporters will transfer up to an aggregate of 42% of the Founder Shares held by each Supporter to Equity Investors. If the aggregate number of transferred Founder Shares is equal to or greater than 273,350 Founder Shares (the “20% Threshold”), Purchaser shall issue a full warrant to the Supporters for each transferred Founder Share transferred above the 20% Threshold; provided that in no event shall the aggregate number of transferred Founder Shares be greater than 574,035. A copy of the Amended and Restated Purchaser Support Agreement is filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference.

     

    On November 30, 2022, Lakeshore also entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the Purchaser, and such investors will also receive an aggregate of 172,368 additional shares from the Purchaser. Altogether, there are 395,339 shares subject to non-redemption agreements and, in connection therewith, the investors will receive an aggregate of 340,085 additional shares of the Purchaser.

     

    Item 7.01. Regulation FD Disclosure.

     

    The information included in Item 1.01 is incorporated by reference into this item.

     

    Item 9.01. Financial Statements and Exhibits.

     

    Exhibit No. Description
    10.1 Form of Amended and Restated Purchaser Support Agreement,
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

     

      

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: December 1, 2022

     

    LAKESHORE ACQUISITION I CORP.

     

    By: /s/ Bill Chen  
    Name: Bill Chen  
    Title: Chief Executive Officer  

     

     

     

     

     

    Get the next $LAAA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LAAA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LAAA
    SEC Filings

    View All

    SEC Form 25-NSE filed by Lakeshore Acquisition I Corp.

    25-NSE - Lakeshore Acquisition I Corp. (0001848000) (Subject)

    12/6/22 5:06:30 PM ET
    $LAAA

    Lakeshore Acquisition I Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits (Amendment)

    8-K/A - Lakeshore Acquisition I Corp. (0001848000) (Filer)

    12/5/22 9:29:51 AM ET
    $LAAA

    Lakeshore Acquisition I Corp. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - Lakeshore Acquisition I Corp. (0001848000) (Filer)

    12/2/22 4:25:50 PM ET
    $LAAA

    $LAAA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Lakeshore Acquisition I Corp. (Amendment)

    SC 13G/A - Lakeshore Acquisition I Corp. (0001848000) (Subject)

    2/14/23 5:00:46 PM ET
    $LAAA

    SEC Form SC 13G/A filed by Lakeshore Acquisition I Corp. (Amendment)

    SC 13G/A - Lakeshore Acquisition I Corp. (0001848000) (Subject)

    5/10/22 4:19:12 PM ET
    $LAAA

    SEC Form SC 13G filed by Lakeshore Acquisition I Corp.

    SC 13G - Lakeshore Acquisition I Corp. (0001848000) (Subject)

    4/29/22 4:03:58 PM ET
    $LAAA

    $LAAA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ProSomnus® Debuts as Publicly Traded Company Focused on Disrupting Obstructive Sleep Apnea Treatment Market with Patient-preferred Precision Oral Appliance Therapy Devices

    Completes business combination with Lakeshore Acquisition I Corp. ProSomnus common stock will trade on Nasdaq Capital Market under ticker symbol "OSA" SAN FRANCISCO, Dec. 06, 2022 (GLOBE NEWSWIRE) --  ProSomnus, Inc. ("the Company"), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea (OSA), today announced the completion of its previously announced business combination with Lakeshore Acquisition I Corp. ("Lakeshore") (NASDAQ:LAAA), a publicly traded special purpose acquisition company. ProSomnus will commence trading on the Nasdaq Global Market under the symbol "OSA" on Dec. 7, 2022. The business combination, which was approved by Lakeshore's shareholders

    12/6/22 5:55:05 PM ET
    $LAAA

    Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus

    SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (NASDAQ:LAAA) ("Lakeshore") today announced that its shareholders have approved all proposals related to the previously announced business combination (the "Business Combination") with ProSomnus Holdings, Inc. ("ProSomnus") at a special meeting of shareholders held on December 2, 2022. Approximately 92.4% of the votes cast at the meeting on the Business Combination proposal, representing approximately 80.5% of Lakeshore's outstanding shares, voted to approve the Business Combination. The closing of the Business Combination is anticipated to occur on or about December 6, 2022.  Following the closing, the combined compan

    12/2/22 4:05:00 PM ET
    $LAAA

    ProSomnus Reports Third Quarter Financial Results and Provides Corporate Update

    Generated record quarterly revenues, and expects merger with Lakeshore Acquisition I Corp. to close in the fourth quarter of 2022 Company Updates 2022 Revenue Guidance to range of $19.0 - $19.5 million for full year 2022 SAN FRANCISCO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- ProSomnus ("the Company"), a pioneer in precision medical devices for the treatment of Obstructive Sleep Apnea ("OSA"), today announced results for the third quarter ended September 30, 2022 and provided a business update. Recent Highlights Record revenues for the first nine months of 2022 of $13.6 million, a 40.6% year-over-year. Revenues in the third quarter were $5.0 million, also a record.Gross margins for the first

    11/29/22 8:30:00 AM ET
    $LAAA